文献
J-GLOBAL ID:202202237069997041
整理番号:22A0890767
重症COVID-19におけるインスリン増殖因子-1(IGF-1)の血清レベルおよび臨床パラメータとの関連性の評価【JST・京大機械翻訳】
Evaluation serum levels of Insulin Growth Factor-1 (IGF-1) and its association with clinical parameters in severe COVID-19
著者 (8件):
Feizollahi Parisa
(Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran)
,
matin Somaieh
(Department of Internal Medicine, Emam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran)
,
matin Somaieh
(Gastrointestinal and Liver Disease Research Center, Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran)
,
Roghani Seyed Askar
(Immunology Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran)
,
Roghani Seyed Askar
(Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran)
,
Mostafaei Shayan
(Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden)
,
Safarzadeh Elham
(Department of Microbiology, Parasitology, and Immunology, Ardabil University of Medical Sciences, Ardabil, Iran)
,
Taghadosi Mahdi
(Department of Immunology, Kermanshah University of Medical Sciences, Kermanshah, Iran)
資料名:
Inflammopharmacology
(Inflammopharmacology)
巻:
30
号:
1
ページ:
199-205
発行年:
2022年
JST資料番号:
W0656A
ISSN:
0925-4692
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)